iShares Biotechnology ETF (NASDAQ:IBB) Holdings Cut by Florin Court Capital LLP

Florin Court Capital LLP cut its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 76.0% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 3,700 shares of the financial services provider’s stock after selling 11,700 shares during the quarter. iShares Biotechnology ETF makes up 0.7% of Florin Court Capital LLP’s portfolio, making the stock its 25th biggest holding. Florin Court Capital LLP’s holdings in iShares Biotechnology ETF were worth $508,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds and other institutional investors have also modified their holdings of the company. Future Financial Wealth Managment LLC bought a new stake in iShares Biotechnology ETF during the first quarter worth approximately $27,000. Bbjs Financial Advisors LLC bought a new position in iShares Biotechnology ETF in the 2nd quarter worth $31,000. Pacifica Partners Inc. boosted its holdings in iShares Biotechnology ETF by 118.2% during the first quarter. Pacifica Partners Inc. now owns 240 shares of the financial services provider’s stock valued at $33,000 after acquiring an additional 130 shares during the period. Crewe Advisors LLC grew its position in shares of iShares Biotechnology ETF by 42.9% in the fourth quarter. Crewe Advisors LLC now owns 260 shares of the financial services provider’s stock valued at $35,000 after purchasing an additional 78 shares during the last quarter. Finally, YHB Investment Advisors Inc. bought a new position in shares of iShares Biotechnology ETF in the first quarter worth about $37,000. 62.45% of the stock is currently owned by hedge funds and other institutional investors.

iShares Biotechnology ETF Stock Down 0.5 %

IBB opened at $144.79 on Friday. iShares Biotechnology ETF has a 12-month low of $111.83 and a 12-month high of $150.17. The stock’s 50 day moving average price is $144.01 and its two-hundred day moving average price is $137.94.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.